Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Vitamin D may lower ICU and intubation rates in COVID-19 patients, with significant benefits observed in older and severe ...

New research indicates that people who contracted COVID-19 early in the pandemic faced a significantly elevated risk of heart ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

Starting in April, COVID-19 patients will have to pay 10 to 30 percent of medical care and drug expenses out of pocket. Health minister Keizo Takemi announced on March 5 that the central ...

Discover new research which delves into the use of cardiac magnetic resonance imaging for detecting myocarditis after ...